bioRxiv Science⌕ Search

Biology subjects

Tsui, D.

Publications and source records attributed to Tsui, D..

3 recordsLinked to original sources

Protein fitness landscapes are simpler under evolutionary distributions

Understanding how mutations combine to shape protein fitness remains a central challenge in biology, driven in part by the prevalence of highorder epistasis. Existing analyses of epistasis, however, implicitly define epistatic interactions under a uniform probability measure over sequence space, even though evolution constrains natural proteins to a highly structured, non-uniform distribution of sequences. Here, we show that the apparent complexity of protein epistasis depends fundamentally on the underlying evolutionary distribution of sequences. We develop an evolution-aware spectral framework that incorporates the evolutionary distribution of amino acids at each sequence position, inducing an orthogonal decomposition under the evolutionary measure while preserving efficient spectral algorithms for scalable analysis. Across diverse protein fitness landscapes, this framework consistently produces more compact spectral representations, explaining more phenotypic variation with fewer epistatic interactions while substantially reducing apparent high-order epistasis. It also enables more accurate recovery of fitness landscapes from limited experimental measurements and concentrates the remaining higher-order interactions into localized, structurally interpretable motifs. These results suggest that a substantial fraction of apparent high-order epistasis arises from defining epistatic interactions under a uniform measure over sequence space and can be resolved by aligning spectral analysis with evolutionary constraints.

evolutionary biology↗

GOLF: A Generative AI Framework for Pathogenicity Prediction of Myocilin OLF Variants

Missense mutations in the MYOC gene, particularly those affecting the olfactomedin (OLF) domain of the myocilin protein, can be causal for open-angle glaucoma--a leading cause of irre-versible blindness. However, predicting the pathogenicity of these mutations remains challenging due to the complex effects of toxic gain-of-function variants and the scarcity of labeled clinical data. Herein, we present GOLF, a generative AI framework for assessing and explaining the pathogenicity of OLF domain variants. GOLF collects and curates a comprehensive dataset of OLF homologs and trains generative models that predict the effect of monoallelic missense mutations. While these models exhibit diverse predictive behaviors, they collectively achieve accurate classification of known pathogenic and benign variants. To interpret their decision mechanisms, GOLF uses a sparse autoencoder (SAE) that reveals the underlying biochemical features exploited by the generative models to predict variant effects. GOLF enables accurate evaluation of disease-causing mutations, supporting early genetic risk stratification for glaucoma and facilitating interpretable investigations into the molecular basis of pathogenic variants.

bioinformatics↗

A large-scale retrospective study in metastatic breast cancer patients using circulating tumor DNA and machine learning to predict treatment outcome and progression-free survival

PurposeMonitoring levels of circulating tumor-derived DNA (ctDNA) represents a non-invasive snapshot of tumor burden and potentially clonal evolution. Here we describe how a novel statistical model that uses serial ctDNA measurements from shallow whole genome sequencing (sWGS) in metastatic breast cancer patients produces a rapid and inexpensive assessment that is predictive of treatment response and progression-free survival. Patients and MethodsA cohort of 188 metastatic breast cancer patients had DNA extracted from serial plasma samples (total 1098, median=4, mean=5.87). Plasma DNA was assessed using sWGS and the tumor fraction in total cell free DNA estimated using ichorCNA. This approach was compared with ctDNA targeted sequencing and serial CA 15-3 measurements. The longitudinal ichorCNA values were used to develop a Bayesian learning model to predict subsequent treatment response. ResultsWe identified a transition point of 7% estimated tumor fraction to stratify patients into different categories of progression risk using ichorCNA estimates and a time-dependent Cox model, validated across different breast cancer subtypes and treatments, outperforming the alternative methods. We then developed a Bayesian learning model to predict subsequent treatment response with a sensitivity of 0.75 and a specificity of 0.66. ConclusionIn patients with metastatic breast cancer, sWGS of ctDNA and ichorCNA provide prognostic and predictive real-time valuable information on treatment response across subtypes and therapies. A prospective large-scale clinical trial to evaluate clinical benefit of early treatment changes based on ctDNA levels is now warranted.

genomics↗